As coronavirus infection continues to spread across the world, experts warn that the virus can leave a person infected throughout his life.
The SARS-CoV-2 beta-coronavirus prompt COVID-19; it belongs to a family of zoonotic pathogens. The virus assaults the respiratory system with flu-like and pneumonia indications that can be fatal for people with existing health conditions.
Professor Włodzimierz Gut from the National Institute of Public Health in Poland says that experts cannot differentiate between an active and inactive infection.
In other cases, the virus will not activate any symptoms and may completely elude detection. While with other coronavirus cases, there is a potential risk that the infection will never honestly go away even when treated.
Professor Gut said:
“Infectiveness and the course of the disease are two different things.
“We use a method that is unable to distinguish between an active and inactive virus.
“Therefore, someone finding the virus after three, four, five weeks is news they have discovered the virus’ genome – an active virus is most likely not there.
On the other hand, Researchers are concentrated on developing a cure in the shortest time possible.
A biotech firm in Germany, for example, is trying to condition the body’s immune system to battle the coronavirus via an intramuscular vaccine.
While the clinical symptoms diminish, parts of the virus remain. Some viruses stay for life The Laboratory of Virology at Wageningen University is also considering fighting the coronavirus by creating complex proteins to use in a vaccine.
Medical scientists have also proposed testing the effectiveness of the existing medicine, like certain anti-HIV drugs.
A specific candidate is Remdesivir; it was previously tested on patients infected with SARS – another coronavirus related disease.
Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID), says that it will take at least 12 months before the first vaccine sees the light of day.
It could be deployed at the earliest, “in a year to a year-and-a-half, no matter how fast you go.” Formerly, The Bill & Melinda Gates Foundation announced its organization with Wellcome and Mastercard to lift coronavirus research funding.
The partnership launched a £95.7million ($125million) fund named as “COVID-19 Therapeutics Accelerator.”
While waiting for a safe vaccine to be developed, the US Centers for Disease Control and Prevention (CDC) said;
The CDC said:
“There is no specific antiviral treatment recommended for COVID-19.
“People with COVID-19 should receive supportive care to help relieve symptoms.
“For severe cases, treatment should include care to support vital organ function.”